Intraperitoneal chemotherapy for gastric cancer with peritoneal disease: experience from Singapore and Japan
10.1007/s10120-016-0660-y
Saved in:
Main Authors: | Kono K., Yong W.-P., Okayama H., Shabbir A., Momma T., Ohki S., Takenoshita S., So J. |
---|---|
Other Authors: | SURGERY |
Format: | Article |
Published: |
Springer Tokyo
2018
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/146720 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Conversion Surgery Post-Intraperitoneal Paclitaxel and Systemic Chemotherapy for Gastric Cancer Carcinomatosis Peritonei. Are We Ready?
by: Chan D.Y.S., et al.
Published: (2018) -
Anaesthesia considerations and techniques for Pressurised IntraPeritoneal Aerosol Chemotherapy (PIPAC)
by: Shree, V., et al.
Published: (2021) -
Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: Synthesis, formulation, characterization and in vitro drug release
by: Zhang, Z., et al.
Published: (2014) -
Contribution of reactivated RUNX3 to inhibition of gastric cancer cell growth following suberoylanilide hydroxamic acid (vorinostat) treatment
by: Huang, C., et al.
Published: (2011) -
Contribution of reactivated RUNX3 to inhibition of gastric cancer cell growth following suberoylanilide hydroxamic acid (vorinostat) treatment
by: Huang, C., et al.
Published: (2012)